These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 18432757)

  • 1. Animal models for candidiasis.
    Romani L
    Curr Protoc Immunol; 2001 May; Chapter 19():Unit 19.6. PubMed ID: 18432757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections.
    Fidel PL; Cutright JL; Sobel JD
    Infect Immun; 1995 Oct; 63(10):4191-4. PubMed ID: 7558342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
    Han Y; Rhew KY
    Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental oral candidiasis in healthy and immunocompromised BALB/c mice].
    Karaman M; Kiray M; Bayrakal V; Bağrıyanık HA; Yılmaz O; Bahar IH
    Mikrobiyol Bul; 2011 Apr; 45(2):336-43. PubMed ID: 21644077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility to vaginal candidiasis.
    Calderon L; Williams R; Martinez M; Clemons KV; Stevens DA
    Med Mycol; 2003 Apr; 41(2):143-7. PubMed ID: 12964847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
    Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
    Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic basis for protection against experimental vaginal candidiasis by peripheral immunization.
    Mulero-Marchese RD; Blank KJ; Sieck TG
    J Infect Dis; 1998 Jul; 178(1):227-34. PubMed ID: 9652445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-organism model of host defense against infection: a novel immunotoxicologic approach to evaluate immunomodulatory drugs.
    Herzyk DJ; Ruggieri EV; Cunningham L; Polsky R; Herold C; Klinkner AM; Badger A; Kerns WD; Bugelski PJ
    Toxicol Pathol; 1997; 25(4):351-62. PubMed ID: 9280118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition of Candida albicans by vaginal cells from naïve mice.
    Steele C; Ozenci H; Luo W; Scott M; Fidel PL
    Med Mycol; 1999 Aug; 37(4):251-9. PubMed ID: 10421860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
    Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine model of concurrent oral and vaginal Candida albicans colonisation.
    Rahman D; Mistry M; Thavaraj S; Naglik JR; Challacombe SJ
    Methods Mol Biol; 2012; 845():527-35. PubMed ID: 22328401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice.
    MacCallum DM; Odds FC
    Mycoses; 2005 May; 48(3):151-61. PubMed ID: 15842329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice.
    Ashman RB; Papadimitriou JM; Fulurija A; Drysdale KE; Farah CS; Naidoo O; Gotjamanos T
    Microb Pathog; 2003 Feb; 34(2):103-13. PubMed ID: 12623278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil depletion increases susceptibility to systemic and vaginal candidiasis in mice, and reveals differences between brain and kidney in mechanisms of host resistance.
    Fulurija A; Ashman RB; Papadimitriou JM
    Microbiology (Reading); 1996 Dec; 142 ( Pt 12)():3487-96. PubMed ID: 9004511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice.
    Stuyt RJ; Netea MG; van Krieken JH; van der Meer JW; Kullberg BJ
    J Infect Dis; 2004 Apr; 189(8):1524-7. PubMed ID: 15073691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow colony-formation in vitro after infection of genetically defined inbred mice with Candida albicans.
    Wanasaengsakul S; Ashman RB
    Microb Pathog; 2004 Apr; 36(4):211-7. PubMed ID: 15001227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene.
    Doyle TC; Nawotka KA; Kawahara CB; Francis KP; Contag PR
    Microb Pathog; 2006 Feb; 40(2):82-90. PubMed ID: 16426810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The dynamics of the invasive growth of Candida albicans in the host's tissues].
    Bykov VL
    Vestn Dermatol Venerol; 1990; (4):25-8. PubMed ID: 2202166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of phospholipase activity of Candida albicans and non albicans isolated from women of reproductive age with vulvovaginal candidiasis in rural area.
    Fule SR; Das D; Fule RP
    Indian J Med Microbiol; 2015; 33(1):92-5. PubMed ID: 25560009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquiritigenin, a licorice flavonoid, helps mice resist disseminated candidiasis due to Candida albicans by Th1 immune response, whereas liquiritin, its glycoside form, does not.
    Lee JY; Lee JH; Park JH; Kim SY; Choi JY; Lee SH; Kim YS; Kang SS; Jang EC; Han Y
    Int Immunopharmacol; 2009 May; 9(5):632-8. PubMed ID: 19264152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.